This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Arrayit Corporation Showcases Advanced Robotic Microarray Technology At Laboratory Automation Conference 2014

SUNNYVALE, Calif., Jan. 21, 2014 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, is currently showcasing the company's advanced robotic systems for microarray printing and scanning at the Society for Laboratory Automation and Screening Conference in San Diego, California, USA from January 18-22, 2014. Sponsored by Agilent Technologies, Molecular Devices, Thermo Scientific, and other automation leaders, the conference tagline "An exceptional array of answers" highlights the central role of microarray technology in drug discovery and screening, biomarker identification, nanotechnology, bioinformatics and other conference focus areas.

Arrayit's patented and proprietary robotic systems utilize micro-robotics, linear drive technology, nanoliter and picoliter contact dispensing, real-time auto-focusing and other advanced approaches to empower the full spectrum of microarray applications required to explore the human genome and proteome, decipher human illnesses, diagnose diseases pre-symptomatically and identify safer and more efficacious medicines. Arrayit offers its 4,000 worldwide technology installations the advantages of flexibility, affordability and high performance in personal and industrial scale product offerings that are intuitive and readily deployed.

Arrayit completed its most successful year as a public company in 2013 by raising more than $2.2m in equity capital, securing financial advice from small cap expert Irwin Zalcberg, adding biotech expert Sid Taubenfeld to the Board, retaining Phil Ruben as General Counsel, leveraging the investor relations expertise of IMS, moving into a new company headquarters, hiring DOCRO, beginning CLIA and ISO laboratory certification and preparing for OvaDx® FDA submission. The company carries significant momentum into the new fiscal year after recording a company-best 150 qualified sales leads at last week's Plant and Animal Genome Conference.

About Arrayit Corporation

Arrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
TSLA $148.72 0.32%
YHOO $27.42 2.20%
AAPL $95.29 0.32%
FB $102.07 2.50%
GOOG $689.67 1.70%


Chart of I:DJI
DOW 16,050.61 +36.23 0.23%
S&P 500 1,866.98 +14.77 0.80%
NASDAQ 4,325.4420 +56.6790 1.33%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs